12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Teva, Watson, Abbott sales and marketing update

Teva and Watson launched generic versions of Prometrium progesterone 100 and 200 mg capsules to prevent endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >